Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther Jacobs

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMC Health Services Research|October 2, 2013
Methods of international health technology assessment agencies for economic evaluations--a comparative analysisTim Mathes, Esther Jacobs, Jana-Carina Morfeld, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Association between regional deprivation and type 2 diabetes incidence in GermanyEsther Jacobs, Thaddäus Tönnies, Wolfgang Rathmann, et al.
Diabetes Care|October 11, 2017
Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in GermanyEsther Jacobs, Annika Hoyer, Ralph Brinks, et al.
International Journal of Technology Assessment in Health Care|June 1, 2017
DEFINING THE RELEVANT OUTCOME MEASURES IN MEDICAL DEVICE ASSESSMENTS: AN ANALYSIS OF THE DEFINITION PROCESS IN HEALTH TECHNOLOGY ASSESSMENTEsther Jacobs, Sunya-Lee Antoine, Barbara Prediger, et al.
International Journal of Pharmaceutics|December 29, 2022
High drug loading nanosized amorphous solid dispersion (NASD) with enhanced in vitro solubility and permeability: Benchmarking conventional ASDGavin P Andrews, Kaijie Qian, Esther Jacobs, et al.
BMC Endocrine Disorders|October 18, 2018
Protocol of a cluster randomized trial to investigate the impact of a type 2 diabetes risk prediction model on change in physical activity in primary careEsther Jacobs, Miguel Tamayo, Joachim Rosenbauer, et al.
Advanced Drug Delivery Reviews|July 9, 2026
Enabling formulations for PROTACs: A line-of-sight to clinicMagda Swedrowska, Rebecca Fransson, Esther Jacobs, et al.
International Journal of Pharmaceutics|June 20, 2020
The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platformYiwei Tian, Esther Jacobs, David S Jones, et al.
Pharmaceutics|August 22, 2019
The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition RangeYiwei Tian, Kaijie Qian, Esther Jacobs, et al.
International Journal of Pharmaceutics|October 20, 2022
Design and scale-up of amorphous drug nanoparticles production via a one-step anhydrous continuous processEsther Jacobs, Kaije Qian, Valerie L Pietsch, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMC Health Services Research|October 2, 2013
Methods of international health technology assessment agencies for economic evaluations--a comparative analysisTim Mathes, Esther Jacobs, Jana-Carina Morfeld, et al.
BMJ Open Diabetes Research & Care|January 8, 2020
Association between regional deprivation and type 2 diabetes incidence in GermanyEsther Jacobs, Thaddäus Tönnies, Wolfgang Rathmann, et al.
Diabetes Care|October 11, 2017
Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data From 65 Million People in GermanyEsther Jacobs, Annika Hoyer, Ralph Brinks, et al.
International Journal of Technology Assessment in Health Care|June 1, 2017
DEFINING THE RELEVANT OUTCOME MEASURES IN MEDICAL DEVICE ASSESSMENTS: AN ANALYSIS OF THE DEFINITION PROCESS IN HEALTH TECHNOLOGY ASSESSMENTEsther Jacobs, Sunya-Lee Antoine, Barbara Prediger, et al.
International Journal of Pharmaceutics|December 29, 2022
High drug loading nanosized amorphous solid dispersion (NASD) with enhanced in vitro solubility and permeability: Benchmarking conventional ASDGavin P Andrews, Kaijie Qian, Esther Jacobs, et al.
BMC Endocrine Disorders|October 18, 2018
Protocol of a cluster randomized trial to investigate the impact of a type 2 diabetes risk prediction model on change in physical activity in primary careEsther Jacobs, Miguel Tamayo, Joachim Rosenbauer, et al.
Advanced Drug Delivery Reviews|July 9, 2026
Enabling formulations for PROTACs: A line-of-sight to clinicMagda Swedrowska, Rebecca Fransson, Esther Jacobs, et al.
International Journal of Pharmaceutics|June 20, 2020
The design and development of high drug loading amorphous solid dispersion for hot-melt extrusion platformYiwei Tian, Esther Jacobs, David S Jones, et al.
Pharmaceutics|August 22, 2019
The Investigation of Flory-Huggins Interaction Parameters for Amorphous Solid Dispersion Across the Entire Temperature and Composition RangeYiwei Tian, Kaijie Qian, Esther Jacobs, et al.
International Journal of Pharmaceutics|October 20, 2022
Design and scale-up of amorphous drug nanoparticles production via a one-step anhydrous continuous processEsther Jacobs, Kaije Qian, Valerie L Pietsch, et al.
Pageof 2